The project of mepolizumab injection **COPD disease has been successfully carried out in clinical trials in China, and now many poor COPD patients have the opportunity to use new drugs
The new drug can block the binding of IL-5 to the receptor on the surface of eosinophils, reduce the growth of eosinophils, and is expected to alleviate a variety of diseases caused by excessive eosinophils. At present, the project has reached the third phase stage, one step away from the market, and the new drug is safe and stable, worthy of the trust of patients!
Now this new drug has carried out free group activities in China, Xiangya Hospital of Central South University, the Second Affiliated Hospital of Nanchang University, the Third Affiliated Hospital of Guangzhou Medical University, the First People's Hospital of Guangzhou, the Third Xiangya Hospital of Central South University, etc
If you are a COPD patient and are in urgent need of new drugs, you can nod your head and say hello, and I will arrange for you to be in the third phase of the ** project!New drugs are all expert help, safe!You can ** the article, collect the article, and give yourself a life-saving guarantee!